tradingkey.logo

BRIEF-NLS Pharmaceutics And Kadimastem Unveil Multi-Target Approach To Diabetes

ReutersFeb 10, 2025 1:43 PM

- Kadimastem KDST.TA:

  • NLS PHARMACEUTICS AND KADIMASTEM UNVEIL MULTI-TARGET APPROACH TO DIABETES, EXPANDING BEYOND GLP-1 THERAPIES

Source text: ID:nPn4kTQGna

Further company coverage: KDST.TA

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI